{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T22:57:19Z","timestamp":1777157839296,"version":"3.51.4"},"reference-count":39,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"abstract":"<jats:p>Receptor activator of nuclear factor-\u03baB ligand (RANKL) is essential for osteoclast differentiation, and hormones and cytokines that stimulate bone resorption increase RANKL expression in stromal\/osteoblastic cells. We have previously shown that PTH and 1,25-dihydroxyvitamin D3 control murine RANKL gene expression in vitro, in part, via an evolutionarily conserved transcriptional enhancer, designated the distal control region (DCR), located 76 kb upstream from the transcription start site. Herein we describe the phenotype of mice lacking this enhancer. Deletion of the DCR reduced PTH and 1,25-dihydroxyvitamin D3 stimulation of RANKL mRNA and osteoclast formation in primary bone marrow cultures as well as stimulation of RANKL mRNA in bone. DCR deletion also reduced basal RANKL mRNA levels in bone, thymus, and spleen. Moreover, mice lacking the DCR exhibited increased bone mass and strength. The increase in bone mass was due to reduced osteoclast and osteoblast formation leading to a low rate of bone remodeling similar to that observed in humans and mice with hypoparathyroidism. These findings demonstrate that hormonal control of RANKL expression via the DCR is a critical determinant of the rate of bone remodeling.<\/jats:p>","DOI":"10.1210\/en.2007-0734","type":"journal-article","created":{"date-parts":[[2007,10,12]],"date-time":"2007-10-12T00:58:58Z","timestamp":1192150738000},"page":"146-153","source":"Crossref","is-referenced-by-count":86,"title":["Targeted Deletion of a Distant Transcriptional Enhancer of the Receptor Activator of Nuclear Factor-\u03baB Ligand Gene Reduces Bone Remodeling and Increases Bone Mass"],"prefix":"10.1210","volume":"149","author":[{"given":"Carlo","family":"Galli","sequence":"first","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases (C.G., Q.F., R.S.W., S.C.M., C.A.O.), University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee A.","family":"Zella","sequence":"first","affiliation":[{"name":"Department of Biochemistry (L.A.Z., J.A.F., J.W.P.), University of Wisconsin-Madison, Madison, Wisconsin 53706"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie A.","family":"Fretz","sequence":"first","affiliation":[{"name":"Department of Biochemistry (L.A.Z., J.A.F., J.W.P.), University of Wisconsin-Madison, Madison, Wisconsin 53706"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"first","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases (C.G., Q.F., R.S.W., S.C.M., C.A.O.), University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Wesley","family":"Pike","sequence":"first","affiliation":[{"name":"Department of Biochemistry (L.A.Z., J.A.F., J.W.P.), University of Wisconsin-Madison, Madison, Wisconsin 53706"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Weinstein","sequence":"first","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases (C.G., Q.F., R.S.W., S.C.M., C.A.O.), University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros C.","family":"Manolagas","sequence":"first","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases (C.G., Q.F., R.S.W., S.C.M., C.A.O.), University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"O\u2019Brien","sequence":"first","affiliation":[{"name":"Center for Osteoporosis and Metabolic Bone Diseases (C.G., Q.F., R.S.W., S.C.M., C.A.O.), University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2007,10,11]]},"reference":[{"key":"2020071612200770900_R1","first-page":"497","author":"Parfitt","year":"2005"},{"key":"2020071612200770900_R2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D.","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone"},{"key":"2020071612200770900_R3","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/en.2003-1097","article-title":"Skeletal abnormalities in Pth-null mice are influenced by dietary calcium.","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612200770900_R4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcb.10623","article-title":"In vivo administration of 1,25-dihydroxyvitamin D-3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.","volume":"90","author":"Ueno","year":"2003","journal-title":"J Cell Biochem"},{"key":"2020071612200770900_R5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2020071612200770900_R6","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/endo.142.9.8356","article-title":"Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.","volume":"142","author":"Ma","year":"2001","journal-title":"Endocrinology"},{"key":"2020071612200770900_R7","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1210\/endo.140.8.6887","article-title":"Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.","volume":"140","author":"Lee","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612200770900_R8","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NF\u03ba B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.","volume":"277","author":"Fu","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071612200770900_R9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","article-title":"The role of the immune system in the pathophysiology of osteoporosis.","volume":"208","author":"Clowes","year":"2005","journal-title":"Immunol Rev"},{"key":"2020071612200770900_R10","first-page":"2739","article-title":"Comparison of the biochemical responses to human parathyroid hormone-(1\u201331)NH2 and hPTH-(1\u201334) in healthy humans.","volume":"84","author":"Fraher","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071612200770900_R11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1210\/endo-101-3-969","article-title":"In vivo evidence for the intermediary role of 3\u2032,5\u2032-cyclic AMP in parathyroid hormone-induced stimulation of 1\u03b1,25-dihydroxyvitamin D3 synthesis in rats.","volume":"101","author":"Horiuchi","year":"1977","journal-title":"Endocrinology"},{"key":"2020071612200770900_R12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/8756-3282(95)80026-M","article-title":"Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and\/or dietary calcium-deficient rats.","volume":"16","author":"Shen","year":"1995","journal-title":"Bone"},{"key":"2020071612200770900_R13","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL.","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612200770900_R14","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jcb.20891","article-title":"Modulation of mouse RANKL gene expression by Runx2 and PKA pathway.","volume":"98","author":"Mori","year":"2006","journal-title":"J Cell Biochem"},{"key":"2020071612200770900_R15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1006\/bbrc.2001.6251","article-title":"Vitamin D-3 augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.","volume":"290","author":"Kitazawa","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071612200770900_R16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcb.10567","article-title":"Vitamin D-3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.","volume":"89","author":"Kitazawa","year":"2003","journal-title":"J Cell Biochem"},{"key":"2020071612200770900_R17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S8756-3282(01)00692-5","article-title":"Cbfa1 does not regulate RANKL gene activity in stromal\/osteoblastic cells.","volume":"30","author":"O\u2019Brien","year":"2002","journal-title":"Bone"},{"key":"2020071612200770900_R18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jcb.20217","article-title":"Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells.","volume":"93","author":"Fan","year":"2004","journal-title":"J Cell Biochem"},{"key":"2020071612200770900_R19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/MCB.25.1.512-522.2005","article-title":"NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes.","volume":"25","author":"Kabe","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2020071612200770900_R20","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/MCB.00356-06","article-title":"Parathyroid hormone controls receptor activator of NF-\u03baB ligand gene expression via a distant transcriptional enhancer.","volume":"26","author":"Fu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2020071612200770900_R21","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/MCB.00353-06","article-title":"Activation of receptor activator of NF-\u03baB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers.","volume":"26","author":"Kim","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2020071612200770900_R22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI11653","article-title":"Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17\u03b2-estradiol.","volume":"107","author":"Di Gregorio","year":"2001","journal-title":"J Clin Invest"},{"key":"2020071612200770900_R23","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength.","volume":"145","author":"O\u2019Brien","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612200770900_R24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1210\/me.2006-0015","article-title":"Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.","volume":"20","author":"Zella","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2020071612200770900_R25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2[-\u0394\u0394 C(T)] method.","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2020071612200770900_R26","doi-asserted-by":"crossref","first-page":"E784","DOI":"10.1152\/ajpendo.00029.2005","article-title":"IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice","volume":"289","author":"O\u2019Brien","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071612200770900_R27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071612200770900_R28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2020071612200770900_R29","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1210\/en.2003-1695","article-title":"Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice.","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"2020071612200770900_R30","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1210\/endo.140.11.7110","article-title":"Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses.","volume":"140","author":"Amling","year":"1999","journal-title":"Endocrinology"},{"key":"2020071612200770900_R31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00003086-199001000-00036","article-title":"Role of transforming growth factor-beta in bone remodeling.","volume":"250","author":"Bonewald","year":"1990","journal-title":"Clin Orthop Relat Res"},{"key":"2020071612200770900_R32","first-page":"701","author":"Manolagas","year":"1996"},{"key":"2020071612200770900_R33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/path.2140","article-title":"Human osteosarcoma cells express functional receptor activator of nuclear factor-\u03baB.","volume":"211","author":"Mori","year":"2007","journal-title":"J Pathol"},{"key":"2020071612200770900_R34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1196\/annals.1346.043","article-title":"Mechanisms involved in skeletal anabolic therapies.","volume":"1068","author":"Martin","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"2020071612200770900_R35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"2020071612200770900_R36","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","article-title":"B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.","volume":"109","author":"Li","year":"2007","journal-title":"Blood"},{"key":"2020071612200770900_R37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200319504","article-title":"Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation.","volume":"112","author":"VanHouten","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071612200770900_R38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S8756-3282(02)00680-4","article-title":"Vector-averaged gravity regulates gene expression of receptor activator of NF-\u03baB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP\/protein kinase A pathway.","volume":"30","author":"Kanematsu","year":"2002","journal-title":"Bone"},{"key":"2020071612200770900_R39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1210\/me.2006-0315","article-title":"Transcriptional control of receptor activator of nuclear factor-\u03baB ligand by the protein kinase A activator forskolin and the transmembrane glycoprotein 130-activating cytokine, oncostatin M, is exerted through multiple distal enhancers.","volume":"21","author":"Kim","year":"2007","journal-title":"Mol Endocrinol"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/1\/146\/8992499\/endo0146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/1\/146\/8992499\/endo0146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T11:46:15Z","timestamp":1684064775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/149\/1\/146\/2454949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,11]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2007-0734","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,11]]}}}